[(1-Benzyl-1H-indazol-3-yl)oxy] acetic acid salt with L. lysine

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Parasitic organism or component thereof or substance...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

548372, A61K 31415, C07D23156

Patent

active

043528139

ABSTRACT:
A new salt of [(1-benzyl-1H-indazol-3-yl)oxy] acetic acid (or bendazac) with L. lysine.
Following oral administrations of this compound in man, the concentrations of bendazac found in the blood are higher than those obtained after administration of bendazac as such.
This discovery extends the therapeutic use of bendazac. In fact, whereas up to now bendazac could only be used topically, the L. lysine salt of bendazac makes it possible to perform therapeutic treatments with the oral route of administration as an agent with a normalizing effect on blood lipids.

REFERENCES:
patent: 3470194 (1969-09-01), Palazzo
Yabuuchi et al., Chem. Abst. 1975, vol. 82, No. 156290y.
Allori et al., Clinica Europea, 1975, vol. XIV, No. 6, pp. 1-11.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

[(1-Benzyl-1H-indazol-3-yl)oxy] acetic acid salt with L. lysine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with [(1-Benzyl-1H-indazol-3-yl)oxy] acetic acid salt with L. lysine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and [(1-Benzyl-1H-indazol-3-yl)oxy] acetic acid salt with L. lysine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-423211

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.